Neonatal exposure to mild hyperoxia causes persistent increases in oxidative stress and immune cells in the lungs of mice without altering lung structure

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 309, Issue 5, 2015, Pages L488-L496

  Bouch, Sheena ^a   O’Reilly, Megan ^a   Harding, Richard ^a   Sozo, Foula ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Heme oxygenase; Macrophages; Newborn; Nitrotyrosine; Supplemental oxygen

Indexed keywords

GALECTIN 3; HEME OXYGENASE 1; 3-NITROTYROSINE; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; OXYGEN; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL; EXPOSURE; FEMALE; GENE EXPRESSION; HYPEROXIA; IMMUNOCOMPETENT CELL; LUNG ALVEOLUS CELL; LUNG LAVAGE; LUNG PARENCHYMA; LUNG STRUCTURE; LYMPHOCYTE; MACROPHAGE; MOUSE; NEONATAL EXPOSURE; NEUTROPHIL; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SEX DIFFERENCE; SHORT TERM SURVIVAL; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; INFLAMMATION; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HEME OXYGENASE-1; HYPEROXIA; INFLAMMATION; MACROPHAGES, ALVEOLAR; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; OXYGEN; PULMONARY ALVEOLI; TYROSINE;

EID: 84938817789     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00359.2014     Document Type: Article

References (74)

1. Ambalavanan N, Carlo WA, D’Angio CT, McDonald SA, Das A, Schendel D, Thorsen P, Higgins RD. Cytokines associated with bronchopulmonarydysplasia or death in extremely low birth weight infants. Pediatrics 123: 1132–1141, 2009.
2. Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, Tarnow-Mordi W. NeOProM: Neonatal Oxygenation Prospective Meta-analysisCollaboration study protocol. BMC Pediatr 11: 6, 2011.
3. Auten R, Mason SN, Tanaka DT, Welty-Wolf K, Whorton MH. Anti-neutrophil chemokine preserves alveolar development in hyperoxiaexposednewborn rats. Am J Physiol Lung Cell Mol Physiol 281: L336–L344, 2001.
4. Auten RL, Mason SN, Auten KM, Brahmajothi M. Hyperoxia impairs postnatal alveolar epithelial development via NADPH oxidase in newborn mice. Am J Physiol Lung Cell Mol Physiol 297: L134–L142, 2009.
5. Balasubramaniam V, Ryan SL, Seedorf GJ, Roth EV, Heumann TR, Yoder MC, Ingram DA, Hogan CJ, Markham NE, Abman SH. Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. Am J Physiol Lung Cell Mol Physiol 298: L315–L323, 2010.
6. Barnes PJ. Alveolar macrophages as orchestrators of COPD. COPD 1:59–70, 2004.
7. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 54: 1119–1138, 1999.
8. Been JV, Lugtenberg MJ, Smets E, van Schayck CP, Kramer BW, Mommers M, Sheikh A. Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis. PLoS Med 11: e1001596, 2014.
9. Berger J, Bhandari V. Animal models of bronchopulmonary dysplasia. The term mouse models. Am J Physiol Lung Cell Mol Physiol 307: L936–L947, 2014.
10. Bhandari V. Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med 15: 223–229, 2010.
11. Bhandari V, Choo-Wing R, Homer RJ, Elias JA. Increased hyperoxiainducedmortality and acute lung injury in IL-13 null mice. J Immunol 178: 4993–5000, 2007.
12. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379: 2162–2172, 2012.
13. Bose C, Laughon M, Allred EN, Van Marter LJ, O’Shea TM, Ehrenkranz RA, Fichorova R, Leviton A. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Pediatr Res 69: 347–353, 2011.
14. Brostrom EB, Akre O, Katz-Salamon M, Jaraj D, Kaijser M. Obstructive pulmonary disease in old age among individuals born preterm. Eur J Epidemiol 28: 79–85, 2013.
15. Broughton S, Roberts A, Fox G, Pollina E, Zuckerman M, Chaudhry S, Greenough A. Prospective study of healthcare utilisation and respiratorymorbidity due to RSV infection in prematurely born infants. Thorax 60: 1039–1044, 2005.
16. Brown JV, Moe-Byrne T, Harden M, McGuire W. Lower vs. higher oxygen concentration for delivery room stabilisation of preterm neonates: systematic review. PLoS One 7: e52033, 2012.
17. Chang HH, Larson J, Blencowe H, Spong CY, Howson CP, Cairns-Smith S, Lackritz EM, Lee SK, Mason E, Serazin AC, Walani S, Simpson JL, Lawn JE; Born Too Soon preterm prevention analysis group. Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet 381: 223–234, 2012.
18. Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol 30: 179–184, 2006.
19. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol 48: 721–731, 1986.
20. Dargaville PA, Kamlin CO, De Paoli AG, Carlin JB, Orsini F, Soll RF, Davis PG. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation. BMC Pediatr 14: 213, 2014.
21. Davis JM, Auten RL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 15: 191–195, 2010.
22. Denis D, Fayon MJ, Berger P, Molimard M, De Lara MT, Roux E, Marthan R. Prolonged moderate hyperoxia induces hyperresponsiveness and airway inflammation in newborn rats. Pediatr Res 50: 515–519, 2001.
23. Doyle LW. Respiratory function at age 8–9 years in extremely low birthweight/very preterm children born in Victoria in 1991–1992. Pediatr Pulmonol 41: 570–576, 2006.
24. Doyle LW, Anderson PJ. Pulmonary and neurological follow-up of extremely preterm infants. Neonatology 97: 388–394, 2010.
25. Farkas I, Maroti Z, Katona M, Endreffy E, Monostori P, Mader K, Turi S. Increased heme oxygenase-1 expression in premature infants with respiratory distress syndrome. Eur J Pediatr 167: 1379–1383, 2008.
26. Fernandez-Gonzalez A, Alex Mitsialis S, Liu X, Kourembanas S. Vasculoprotective effects of heme oxygenase-1 in a murine model of hyperoxia-induced bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 302: L775–L784, 2012.
27. Filippone M, Bonetto G, Corradi M, Frigo AC, Baraldi E. Evidence of unexpected oxidative stress in airways of adolescents born very pre-term. Eur Respir J 40: 1253–1259, 2012.
28. Gessner BD, Chimonas MA. Asthma is associated with preterm birth but not with small for gestational age status among a population-based cohort of Medicaid-enrolled children 10 years of age. Thorax 62: 231–236, 2007.
29. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 93: 712–718, 1994.
30. Gupta S, Sinha SK, Donn SM. Ventilatory management and bronchopulmonary dysplasia in preterm infants. Semin Fetal Neonatal Med 14: 367–373, 2009.
31. Hay WW Jr, Bell EF. Oxygen therapy, oxygen toxicity, and the STOP-ROP trial. Pediatrics 105: 424–425, 2000.
32. Hershenson MB, Garland A, Kelleher MD, Zimmermann A, Hernandez C, Solway J. Hyperoxia-induced airway remodeling in immature rats. Correlation with airway responsiveness. Am Rev Respir Dis 146: 1294–1300, 1992.
33. Horvat JC, Beagley KW, Wade MA, Preston JA, Hansbro NG, Hickey DK, Kaiko GE, Gibson PG, Foster PS, Hansbro PM. Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med 176: 556–564, 2007.
34. Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 100: 145–157, 2014.
35. Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr 23: 167–172, 2011.
36. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 328: 861–868, 1993.
37. Khadawardi E, Al Hazzani F. Oxygen saturation and outcomes in preterm infants The BOOST II United Kingdom, Australia, and New Zealand Collaborative Groups. J Clil Neonatol 2: 73–75, 2013.
38. Kilbride HW, Gelatt MC, Sabath RJ. Pulmonary function and exercise capacity for ELBW survivors in preadolescence: effect of neonatal chronic lung disease. J Pediatr 143: 488–493, 2003.
39. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed 72: F90–96, 1995.
40. Li Z, Zeki R, Hilder L, Sullivan E. Australia’s Mothers and Babies 2011. Perinatal Statistics Series 28: 2013.
41. Lim K, Wheeler KI, Gale TJ, Jackson HD, Kihlstrand JF, Sand C, Dawson JA, Dargaville PA. Oxygen saturation targeting in preterm infants receiving continuous positive airway pressure. J Pediatr 164: 730–736.e1, 2014.
42. Maniscalco WM, Watkins RH, D’Angio CT, Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 16: 557–567, 1997.
43. Mauad T, Silva LF, Santos MA, Grinberg L, Bernardi FD, Martins MA, Saldiva PH, Dolhnikoff M. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am J Respir Crit Care Med 170: 857–862, 2004.
44. McGrath-Morrow SA, Cho C, Soutiere S, Mitzner W, Tuder R. The effect of neonatal hyperoxia on the lung of p21Waf1/Cip1/Sdi1-deficient mice. Am J Respir Cell Mol Biol 30: 635–640, 2004.
45. McGrath-Morrow SA, Stahl J. Apoptosis in neonatal murine lung exposed to hyperoxia. Am J Respir Cell Mol Biol 25: 150–155, 2001.
46. O’Reilly M, Hansbro PM, Horvat JC, Beckett EL, Harding R, Sozo F. Bronchiolar remodeling in adult mice following neonatal exposure to hyperoxia: relation to growth. Anat Rec 297: 758–769, 2014.
47. O’Reilly M, Harding R, Sozo F. Altered small airways in aged mice following neonatal exposure to hyperoxic gas. Neonatology 105: 39–45, 2014.
48. O’Reilly M, Hooper SB, Allison BJ, Flecknoe SJ, Snibson K, Harding R, Sozo F. Persistent bronchiolar remodeling following brief ventilation of the very immature ovine lung. Am J Physiol Lung Cell Mol Physiol 297: L992–L1001, 2009.
49. O’Reilly M, Thebaud B. Animal models of bronchopulmonary dysplasia. The term rat models. Am J Physiol Lung Cell Mol Physiol 307: L948–L958, 2014.
50. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
51. Rahman I. Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem Pharmacol 64: 935–942, 2002.
52. Ralser E, Mueller W, Haberland C, Fink FM, Gutenberger KH, Strobl R, Kiechl-Kohlendorfer U. Rehospitalization in the first 2 years of life in children born preterm. Acta Paediatr 101: e1–5, 2012.
53. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev CD004454, 2006.
54. Rosanna DP, Salvatore C. Reactive oxygen species, inflammation, and lung diseases. Curr Pharm Des 18: 3889–3900, 2012.
55. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583–650, 2006.
56. Saetta M, Ghezzo H, Kim WD, King M, Angus GE, Wang NS, Cosio MG. Loss of alveolar attachments in smokers. A morphometric correlate of lung function impairment. Am Rev Respir Dis 132: 894–900, 1985.
57. Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y, Solimano A, Roberts RS. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA 309: 2111–2120, 2013.
58. Smith LJ, McKay KO, van Asperen PP, Selvadurai H, Fitzgerald DA. Normal development of the lung and premature birth. Paediatr Respir Rev 11: 135–142, 2010.
59. Smith LJ, van Asperen PP, McKay KO, Selvadurai H, Fitzgerald DA. Reduced exercise capacity in children born very preterm. Pediatrics 122: e287–293, 2008.
60. Speer CP. Pulmonary inflammation and bronchopulmonary dysplasia. J Perinatol 26, Suppl 1: S57–62; discussion S63-54, 2006.
61. Stevens TP, Finer NN, Carlo WA, Szilagyi PG, Phelps DL, Walsh MC, Gantz MG, Laptook AR, Yoder BA, Faix RG, Newman JE, Das A, Do BT, Schibler K, Rich W, Newman NS, Ehrenkranz RA, Peralta- Carcelen M, Vohr BR, Wilson-Costello DE, Yolton K, Heyne RJ, Evans PW, Vaucher YE, Adams-Chapman I, McGowan EC, Bodnar A, Pappas A, Hintz SR, Acarregui MJ, Fuller J, Goldstein RF, Bauer CR, O’Shea TM, Myers GJ, Higgins RD; SUPPORT Study Group of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). J Pediatr 165: 240–249.e4, 2014.
62. Tan SM, Stefanovic N, Tan G, Wilkinson-Berka JL, de Haan JB. Lack of the antioxidant glutathione peroxidase-1 (GPx1) exacerbates retinopathy of prematurity in mice. Invest Ophthal Vis Sci 54: 555–562, 2013.
63. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, Archer SL. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxiainducedlung injury: evidence that angiogenesis participates in alveolarization. Circulation 112: 2477–2486, 2005.
64. Tin W, Gupta S. Optimum oxygen therapy in preterm babies. Arch Dis Child Fetal Neonatal Ed 92: F143–147, 2007.
65. Trembath A, Laughon MM. Predictors of bronchopulmonary dysplasia. Clin Perinatol 39: 585–601, 2012.
66. van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 272: 7617–7625, 1997.
67. Vento M, Moro M, Escrig R, Arruza L, Villar G, Izquierdo I, Roberts LJ, Arduini A 2nd, Escobar JJ, Sastre J, Asensi MA. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 124: 439–449, 2009.
68. Waitz M, Schmid MB, Fuchs H, Mendler MR, Dreyhaupt J, Hummler HD. Effects of automated adjustment of the inspired oxygen on fluctuations of arterial and regional cerebral tissue oxygenation in preterm infants with frequent desaturations. J Pediatr 166: 240–4.e1, 2015.
69. Wang H, Jafri A, Martin RJ, Nnanabu J, Farver C, Prakash YS, MacFarlane PM. Severity of neonatal hyperoxia determines structural and functional changes in developing mouse airway. Am J Physiol Lung Cell Mol Physiol 307: L295–L301, 2014.
70. Warner BB, Stuart LA, Papes RA, Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol Lung Cell Mol Physiol 275: L110–L117, 1998.
71. Weibel ER. Morphometry of the Human Lung. New York: Springer, 1963.
72. Yee M, Chess PR, McGrath-Morrow SA, Wang Z, Gelein R, Zhou R, Dean DA, Notter RH, O’Reilly MA. Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity. Am J Physiol Lung Cell Mol Physiol 297: L641–L649, 2009.
73. Yee M, Vitiello PF, Roper JM, Staversky RJ, Wright TW, McGrath- Morrow SA, Maniscalco WM, Finkelstein JN, O’Reilly MA. Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. Am J Physiol Lung Cell Mol Physiol 291: L1101–L1111, 2006.
74. Zuberi RI, Hsu DK, Kalayci O, Chen HY, Sheldon HK, Yu L, Apgar JR, Kawakami T, Lilly CM, Liu FT. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol 165: 2045–2053, 2004.